SCHEMBL369633

SCHEMBL369633

Nc1nnc(-c2ccncc2)s1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 12/20 1.00
ALDH1A1 P00352 8/20 1.00
HSD17B10 Q99714 5/20 1.00
HPGD P15428 4/20 1.00
MGAM O43451 4/20 0.62
GAA P10253 4/20 0.62
SI P14410 4/20 0.62
MGAM2 Q2M2H8 4/20 0.62
SMN1; SMN2 Q16637 4/20 0.62
LMNA P02545 1/20 0.62
NOTUM Q6P988 1/20 0.62
NPC1 O15118 3/20 0.56
RAB9A P51151 3/20 0.56
MAPT P10636 2/20 0.56
TP53 P04637 2/20 0.56
POLB P06746 1/20 0.55
ALOX15 P16050 1/20 0.55
CSNK2A2 P19784 1/20 0.55
CSNK2B P67870 1/20 0.55
CSNK2A1 P68400 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10561406 0.84 KDM4E (0.71) KDM4EALDH1A1HSD17B10HPGDGAA
SCHEMBL45441 0.80 KDM4E (0.67) KDM4EALDH1A1HSD17B10HPGDMGAM
SCHEMBL28851907 0.80 KDM4E (0.70) KDM4EALDH1A1HSD17B10HPGDMGAM
SCHEMBL21408723 0.79 KDM4E (0.66) KDM4EALDH1A1HSD17B10HPGDMGAM
SCHEMBL29845591 0.79 KDM4E (0.64) KDM4EALDH1A1HSD17B10HPGDMGAM
Hydrochloric Acid SCHEMBL3691525 0.78 KDM4E (0.64) KDM4EALDH1A1HSD17B10HPGDMGAM
SCHEMBL23918236 0.77 KDM4E (0.66) KDM4EALDH1A1HSD17B10HPGDMGAM
SCHEMBL6902047 0.77 ALDH1A1 (1.00) KDM4EALDH1A1HSD17B10HPGDMGAM
SCHEMBL1143313 0.77 KDM4E (0.66) KDM4EALDH1A1HSD17B10HPGDMGAM
SCHEMBL1143676 0.77 KDM4E (1.00) KDM4EALDH1A1HSD17B10HPGDMGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118255729-A Method for synthesizing 2-amino-5-substituted-1, 3, 4-thiadiazole 陕西科技大学 2024-06-28 CN claimed
CN-101691662-B Carbon steel pickling corrosion inhibitor and preparation method and application thereof NANJING UNIVERSITY OF TECHNOLOGY 2011-01-12 CN claimed
US-20100234377-A1 PIPERAZINE COMPOUNDS FOR THE INHIBITION OF HAEMATOPOIETIC PROSTAGLANDIN D SYNTHASE EVOTEC AG (DE) 2010-09-16 US claimed
CN-101691662-A Carbon steel pickling corrosion inhibitor and preparation method and application thereof NANJING UNIVERSITY OF TECHNOLOGY 2010-04-07 CN claimed
US-12540274-B2 Electrochromic composition and electrochromic device TAI YING OPTRONICS CO., LTD. (TW) 2026-02-03 US disclosed
CN-121342819-A 5-Chloro-3-methyl-1-phenyl-4-pyrazol-formald 2-amino-5- (4-pyridyl) -1,3, 4-thiadiazole compound, and preparation method and application thereof 淮阴师范学院 2026-01-16 CN disclosed
CN-121342819-A 5-Chloro-3-methyl-1-phenyl-4-pyrazol-formald 2-amino-5- (4-pyridyl) -1,3, 4-thiadiazole compound, and preparation method and application thereof 淮阴师范学院 2026-01-16 CN disclosed
CN-120077028-A Thiadiazole derivative, composition and application thereof 北京丹擎医药科技有限公司 2025-05-30 CN disclosed
US-20250136861-A1 ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC DEVICE TAI YING OPTRONICS CO., LTD. (TW) 2025-05-01 US disclosed
CN-119371374-A Green synthesis method of 2-amino-5-aryl-1, 3, 4-thiadiazole 陕西科技大学 2025-01-28 CN disclosed
US-12139635-B2 Coatings for waterproofing electronic components HENKEL AG & CO. KGAA (DE) 2024-11-12 US disclosed
US-20240270735-A1 CDK19-Selective Inhibitors, and Methods of Use Thereof CHAN ZUCKERBERG BIOHUB, INC. 2024-08-15 US disclosed
EP-1558607-A1 COMPOSITIONS USEFUL AS INHIBITORS OF ROCK AND OTHER PROTEIN KINASES Vertex Pharmaceuticals Incorporated (US) 2005-08-03 EP disclosed
WO-2005005435-A1 SPIRO ′1-AZABICYCLO ′2.2.2!OCTAN-3,5′-OXAZOLIDIN -2′-ONE! DERIVATIVES WITH AFFINITY TO THE ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR ASTRAZENECA AB (SE) 2005-01-20 WO disclosed
US-20040122016-A1 Compositions useful as inhibitors of rock and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED 2004-06-24 US disclosed
WO-2004041813-A1 COMPOSITIONS USEFUL AS INHIBITORS OF ROCK AND OTHER PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-05-21 WO disclosed
EP-1054876-A1 1,3,4-THIADIAZOLES DERIVATIVES AS KYN-OH INHIBITORS PHARMACIA & UPJOHN S.p.A. (IT) 2000-11-29 EP disclosed
WO-1999028309-A1 1,3,4-THIADIAZOLES DERIVATIVES AS KYN-OH INHIBITORS PHARMACIA & UPJOHN S.P.A. (IT) 1999-06-10 WO disclosed
US-4271166-A N-(1,3,4-Thiadiazol-2-yl)benzamides ELI LILLY AND COMPANY (US) 1981-06-02 US disclosed
US-4141984-A INSECTICIDES ELI LILLY AND COMPANY (US) 1979-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12540274-B2 Electrochromic composition and electrochromic device CHRM1, CHRM2, TYR KDM4E 404/4885ALDH1A1 1132/4885HSD17B10 3023/4885
US-20240270735-A1 CDK19-Selective Inhibitors, and Methods of Use Thereof CDK19, CDK9, CDK1 KDM4E 904/4885ALDH1A1 4629/4885HSD17B10 1436/4885
US-20040122016-A1 Compositions useful as inhibitors of rock and other protein kinases ROCK1, ROCK2, PRKCH KDM4E 2286/4885ALDH1A1 4771/4885HSD17B10 3750/4885
US-20100234377-A1 PIPERAZINE COMPOUNDS FOR THE INHIBITION OF HAEMATOPOIETIC PROSTAGLANDIN D SYNTHASE HPGDS, PTGDR, PTGIS KDM4E 3580/4885ALDH1A1 614/4885HSD17B10 2479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.